Cargando…

iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines

Computational vaccine design, also known as computational vaccinology, encompasses epitope mapping, antigen selection and immunogen design using computational tools. The iVAX toolkit is an integrated set of tools that has been in development since 1998 by De Groot and Martin. It comprises a suite of...

Descripción completa

Detalles Bibliográficos
Autores principales: Moise, Leonard, Gutierrez, Andres, Kibria, Farzana, Martin, Rebecca, Tassone, Ryan, Liu, Rui, Terry, Frances, Martin, Bill, De Groot, Anne S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635942/
https://www.ncbi.nlm.nih.gov/pubmed/26155959
http://dx.doi.org/10.1080/21645515.2015.1061159
_version_ 1782399577635160064
author Moise, Leonard
Gutierrez, Andres
Kibria, Farzana
Martin, Rebecca
Tassone, Ryan
Liu, Rui
Terry, Frances
Martin, Bill
De Groot, Anne S
author_facet Moise, Leonard
Gutierrez, Andres
Kibria, Farzana
Martin, Rebecca
Tassone, Ryan
Liu, Rui
Terry, Frances
Martin, Bill
De Groot, Anne S
author_sort Moise, Leonard
collection PubMed
description Computational vaccine design, also known as computational vaccinology, encompasses epitope mapping, antigen selection and immunogen design using computational tools. The iVAX toolkit is an integrated set of tools that has been in development since 1998 by De Groot and Martin. It comprises a suite of immunoinformatics algorithms for triaging candidate antigens, selecting immunogenic and conserved T cell epitopes, eliminating regulatory T cell epitopes, and optimizing antigens for immunogenicity and protection against disease. iVAX has been applied to vaccine development programs for emerging infectious diseases, cancer antigens and biodefense targets. Several iVAX vaccine design projects have had success in pre-clinical studies in animal models and are progressing toward clinical studies. The toolkit now incorporates a range of immunoinformatics tools for infectious disease and cancer immunotherapy vaccine design. This article will provide a guide to the iVAX approach to computational vaccinology.
format Online
Article
Text
id pubmed-4635942
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-46359422016-02-03 iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines Moise, Leonard Gutierrez, Andres Kibria, Farzana Martin, Rebecca Tassone, Ryan Liu, Rui Terry, Frances Martin, Bill De Groot, Anne S Hum Vaccin Immunother Research Paper Computational vaccine design, also known as computational vaccinology, encompasses epitope mapping, antigen selection and immunogen design using computational tools. The iVAX toolkit is an integrated set of tools that has been in development since 1998 by De Groot and Martin. It comprises a suite of immunoinformatics algorithms for triaging candidate antigens, selecting immunogenic and conserved T cell epitopes, eliminating regulatory T cell epitopes, and optimizing antigens for immunogenicity and protection against disease. iVAX has been applied to vaccine development programs for emerging infectious diseases, cancer antigens and biodefense targets. Several iVAX vaccine design projects have had success in pre-clinical studies in animal models and are progressing toward clinical studies. The toolkit now incorporates a range of immunoinformatics tools for infectious disease and cancer immunotherapy vaccine design. This article will provide a guide to the iVAX approach to computational vaccinology. Taylor & Francis 2015-07-09 /pmc/articles/PMC4635942/ /pubmed/26155959 http://dx.doi.org/10.1080/21645515.2015.1061159 Text en © 2015 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License http://creativecommons.org/licenses/by-nc/3.0/, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Research Paper
Moise, Leonard
Gutierrez, Andres
Kibria, Farzana
Martin, Rebecca
Tassone, Ryan
Liu, Rui
Terry, Frances
Martin, Bill
De Groot, Anne S
iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines
title iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines
title_full iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines
title_fullStr iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines
title_full_unstemmed iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines
title_short iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines
title_sort ivax: an integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635942/
https://www.ncbi.nlm.nih.gov/pubmed/26155959
http://dx.doi.org/10.1080/21645515.2015.1061159
work_keys_str_mv AT moiseleonard ivaxanintegratedtoolkitfortheselectionandoptimizationofantigensandthedesignofepitopedrivenvaccines
AT gutierrezandres ivaxanintegratedtoolkitfortheselectionandoptimizationofantigensandthedesignofepitopedrivenvaccines
AT kibriafarzana ivaxanintegratedtoolkitfortheselectionandoptimizationofantigensandthedesignofepitopedrivenvaccines
AT martinrebecca ivaxanintegratedtoolkitfortheselectionandoptimizationofantigensandthedesignofepitopedrivenvaccines
AT tassoneryan ivaxanintegratedtoolkitfortheselectionandoptimizationofantigensandthedesignofepitopedrivenvaccines
AT liurui ivaxanintegratedtoolkitfortheselectionandoptimizationofantigensandthedesignofepitopedrivenvaccines
AT terryfrances ivaxanintegratedtoolkitfortheselectionandoptimizationofantigensandthedesignofepitopedrivenvaccines
AT martinbill ivaxanintegratedtoolkitfortheselectionandoptimizationofantigensandthedesignofepitopedrivenvaccines
AT degrootannes ivaxanintegratedtoolkitfortheselectionandoptimizationofantigensandthedesignofepitopedrivenvaccines